TAP
Biosystems, a leading supplier of innovative cell culture systems and
consumables for life science applications, is delighted to announce that
Professor Julie Daniels' Group at the UCL Institute of Ophthalmology will be
presenting her latest research on the use of stem cells for corneal
regeneration at the world's largest gathering of international eye and vision
researchers, ARVO (Association for Research in Vision and Ophthalmology)
meeting on May 6
th - 10
th in Fort Lauderdale, USA.
Professor
Daniels, who has pioneered the clinical use of stem cells for human
ocular surface regeneration since 1999, has been
invited to present a keynote address, which will take place on Sunday May 6
th
at 12 noon in the Floridian Ballroom. Her presentation will include a review of
the use of biomimetic cornea, as well as her own work and collaboration with
TAP Biosystems on using epithelial stem cells to form a biomimetic cornea using
the novel RAFT
TM (Real Architecture for 3D Tissue
TM) process for creating
collagen based tissue equivalents. In addition to this, senior scientists in
the Daniels' Group will also be presenting five talks and three posters on
their research using stem cells to repair the ocular surface.
Professor
Daniels, who has been collaborating with TAP Biosystems since 2008, will
present data to show that the RAFT process can create corneal tissue which
closely mimics the cells'
in vivo
environment and supports stem cell growth, offering the potential to improve
significantly on current success rates of ocular surface transplant surgery.
Dr
Rosemary Drake, CSO at TAP Biosystems stated: "We are delighted that Professor
Daniels' critical research has been given such a substantial platform at this
prestigious Ophthalmology Conference because she is one of the founding
scientists in the application of stem cells for regeneration of the human cornea.
The data from the Daniels' group will show the RAFT process delivers a realistic
collagen-based corneal tissue equivalent, which could in future be more
effective than current clinical standards and may potentially really improve
treatment for patients suffering from blinding ocular surface damage."
For more information visit
www.tapbiosystems.com
Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!
Request your free copies HERE
Popular this Month
Top 10 most popular articles this month
Today's Picks
Looking for a Supplier?
Search by company or by product
Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.
Lab Bulletin is published by newleaf marketing communications ltd.